Skip Navigation


Carcinogenesis Advance Access originally published online on June 19, 2003
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
24/8/1369    most recent
bgg091v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (101)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Chen, C.
Right arrow Articles by Kong, A.-N.T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chen, C.
Right arrow Articles by Kong, A.-N.T.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Carcinogenesis, Vol. 24, No. 8, 1369-1378, August 2003
© 2003 Oxford University Press

MOLECULAR EPIDEMIOLOGY AND CANCER PREVENTION

Epigallocatechin-3-gallate-induced stress signals in HT-29 human colon adenocarcinoma cells

Chi Chen, Guoxiang Shen, Vidya Hebbar, Rong Hu, Edward D. Owuor and A.-N.Tony Kong1

Department of Pharmaceutics, Ernest-Mario School of Pharmacy, Rutgers, The State University of New Jersey, Piscataway, NJ 08854, USA

1 To whom correspondence should be addressed Email: kongt{at}cop.rutgers.edu

Epigallocatechin-3-gallate (EGCG), a major component in green tea polyphenols, has been proven to suppress colonic tumorigenesis in animal models and epidemiological studies. As EGCG is retained in the gastrointestinal tract after oral administration, this pharmacokinetics property gives it the potential to function as a chemopreventive agent against colon cancer. In this study, human colorectal carcinoma HT-29 cells were treated with EGCG to examine the anti-proliferative and pro-apoptotic effects of EGCG, as well as the molecular mechanism underlying these effects. Cell viability assay, nuclear staining, DNA fragmentation, caspase assay, cytochrome c release, DiOC6(3) staining, mitogen-activated protein kinases (MAPK) phosphorylation and trypan blue exclusion assays, were utilized to dissect the signaling pathways induced by EGCG. After 36 h treatment, EGCG inhibited HT-29 cell growth with an IC50 of ~100 µM. HT-29 cells treated with doses higher than 100 µM showed apparent nuclear condensation and fragmentation, which was confirmed by DNA laddering. Caspase-3 and -9 activation was detected after 12 h treatment, accompanied by mitochondrial transmembrane potential transition and cytochrome c release. Activation of MAPKs was detected as early signaling event elicited by EGCG. Inhibition of c-Jun N-terminal kinase (JNK) pathway showed the involvement of JNK in EGCG-induced cytochrome c release and cell death. EGCG-induced JNK activation was blocked by the antioxidants glutathione and N-acetyl-L-cysteine, suggesting that the cell death signaling was potentially triggered by oxidative stress. In summary, our results from this study suggest that in HT-29 human colon cancer cells (i) EGCG treatment causes damage to mitochondria, and (ii) JNK mediates EGCG-induced apoptotic cell death.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 CarcinogenesisHome page
S. Adachi, M. Shimizu, Y. Shirakami, J. Yamauchi, H. Natsume, R. Matsushima-Nishiwaki, S. To, I.B. Weinstein, H. Moriwaki, and O. Kozawa
(-)-Epigallocatechin gallate downregulates EGF receptor via phosphorylation at Ser1046/1047 by p38 MAPK in colon cancer cells
Carcinogenesis, September 1, 2009; 30(9): 1544 - 1552.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
T. Miura, M. Chiba, K. Kasai, H. Nozaka, T. Nakamura, T. Shoji, T. Kanda, Y. Ohtake, and T. Sato
Apple procyanidins induce tumor cell apoptosis through mitochondrial pathway activation of caspase-3
Carcinogenesis, March 1, 2008; 29(3): 585 - 593.
[Abstract] [Full Text] [PDF]

Home page
 Bioscience HorizonsHome page
S. Brierley-Hobson
Binding of (-)-epigallocatechin-3-gallate to the Hsp70 ATPase domain may promote apoptosis in colorectal cancer
Bioscience Horizons, March 1, 2008; 1(1): 9 - 18.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
A. Y. Issa, S. R. Volate, S. J. Muga, D. Nitcheva, T. Smith, and M. J. Wargovich
Green tea selectively targets initial stages of intestinal carcinogenesis in the AOM-ApcMin mouse model
Carcinogenesis, September 1, 2007; 28(9): 1978 - 1984.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
C.M. Payne, C. Weber, C. Crowley-Skillicorn, K. Dvorak, H. Bernstein, C. Bernstein, H. Holubec, B. Dvorakova, and H. Garewal
Deoxycholate induces mitochondrial oxidative stress and activates NF-{kappa}B through multiple mechanisms in HCT-116 colon epithelial cells
Carcinogenesis, January 1, 2007; 28(1): 215 - 222.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
Y.-L. Hsu, C.-Y. Cho, P.-L. Kuo, Y.-T. Huang, and C.-C. Lin
Plumbagin (5-Hydroxy-2-methyl-1,4-naphthoquinone) Induces Apoptosis and Cell Cycle Arrest in A549 Cells through p53 Accumulation via c-Jun NH2-Terminal Kinase-Mediated Phosphorylation at Serine 15 in Vitro and in Vivo
J. Pharmacol. Exp. Ther., August 1, 2006; 318(2): 484 - 494.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
T. Ikegami, Y. Matsuzaki, M. Al Rashid, S. Ceryak, Y. Zhang, and B. Bouscarel
Enhancement of DNA topoisomerase I inhibitor-induced apoptosis by ursodeoxycholic acid
Mol. Cancer Ther., January 1, 2006; 5(1): 68 - 79.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
M. Gago-Dominguez, J. E. Castelao, M. C. Pike, A. Sevanian, and R. W. Haile
Role of Lipid Peroxidation in the Epidemiology and Prevention of Breast Cancer
Cancer Epidemiol. Biomarkers Prev., December 1, 2005; 14(12): 2829 - 2839.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
D. Porath, C. Riegger, J. Drewe, and J. Schwager
Epigallocatechin-3-gallate Impairs Chemokine Production in Human Colon Epithelial Cell Lines
J. Pharmacol. Exp. Ther., December 1, 2005; 315(3): 1172 - 1180.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
Z. Hou, S. Sang, H. You, M.-J. Lee, J. Hong, K.-V. Chin, and C. S. Yang
Mechanism of Action of (-)-Epigallocatechin-3-Gallate: Auto-oxidation-Dependent Inactivation of Epidermal Growth Factor Receptor and Direct Effects on Growth Inhibition in Human Esophageal Cancer KYSE 150 Cells
Cancer Res., September 1, 2005; 65(17): 8049 - 8056.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
M. Kim, A. Murakami, K. Kawabata, and H. Ohigashi
(-)-Epigallocatechin-3-gallate promotes pro-matrix metalloproteinase-7 production via activation of the JNK1/2 pathway in HT-29 human colorectal cancer cells
Carcinogenesis, September 1, 2005; 26(9): 1553 - 1562.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
M. Shimizu, A. Deguchi, J. T.E. Lim, H. Moriwaki, L. Kopelovich, and I. B. Weinstein
(-)-Epigallocatechin Gallate and Polyphenon E Inhibit Growth and Activation of the Epidermal Growth Factor Receptor and Human Epidermal Growth Factor Receptor-2 Signaling Pathways in Human Colon Cancer Cells
Clin. Cancer Res., April 1, 2005; 11(7): 2735 - 2746.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
S. J. Baek, J.-S. Kim, F. R. Jackson, T. E. Eling, M. F. McEntee, and S.-H. Lee
Epicatechin gallate-induced expression of NAG-1 is associated with growth inhibition and apoptosis in colon cancer cells
Carcinogenesis, December 1, 2004; 25(12): 2425 - 2432.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
H. Nakagawa, K. Hasumi, J.-T. Woo, K. Nagai, and M. Wachi
Generation of hydrogen peroxide primarily contributes to the induction of Fe(II)-dependent apoptosis in Jurkat cells by (-)-epigallocatechin gallate
Carcinogenesis, September 1, 2004; 25(9): 1567 - 1574.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
G. Fassina, R. Vene, M. Morini, S. Minghelli, R. Benelli, D. M. Noonan, and A. Albini
Mechanisms of Inhibition of Tumor Angiogenesis and Vascular Tumor Growth by Epigallocatechin-3-Gallate
Clin. Cancer Res., July 15, 2004; 10(14): 4865 - 4873.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
J. K. Kundu, H.-K. Na, K.-S. Chun, Y.-K. Kim, S. J. Lee, S. S. Lee, O.-S. Lee, Y.-C. Sim, and Y.-J. Surh
Inhibition of Phorbol Ester-Induced COX-2 Expression by Epigallocatechin Gallate in Mouse Skin and Cultured Human Mammary Epithelial Cells
J. Nutr., November 1, 2003; 133(11): 3805S - 3810.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.